Key result
Extended SPARK model improves post-surgery adverse kidney outcome prediction with a C-index of ~0.87.
Why the study?
Postoperative acute kidney injury is a critical complication with both short- and long-term adverse kidney outcomes, and existing prediction models lacked mid-to-long-term risk assessment.
Does an extended SPARK model improve prediction of mid-to-long-term adverse kidney outcomes in patients undergoing major non-cardiac surgery?
Cohort (n=138,812)
Yes
Does an extended SPARK model improve prediction of mid-to-long-term adverse kidney outcomes in patients undergoing major non-cardiac surgery?
The addition of PO-AKI stage and history of malignancy to the SPARK model significantly improves mid-to-long-term postoperative risk prediction for mortality or dialysis after non-cardiac surgery.
Answers are grounded in this paper and cite their sources.
May aid mid-to-long-term risk stratification after noncardiac surgery; leaves open prospective validation before routine adoption.
Background: Postoperative acute kidney injury (PO-AKI) is a critical complication of adverse kidney outcomes, both short and long-term. We aimed to expand our pre-existing PO-AKI prediction model to predict mid-to long-term adverse kidney outcomes. Methods: We included patients who underwent major non-cardiac surgeries from the original SPARK cohort, two external validation cohorts, and a temporal validation cohort. Mid-to-long-term adverse kidney outcomes were defined as end-stage kidney disease progression or death within 1 or 3 years after surgery. We verified and tuned the original Simple Postoperative AKI RisK (SPARK) model to predict mid-to-long-term adverse kidney events. Results: We included 33 636 patients in development, 71 232 patients in external validation, and 33 944 patients in temporal validation cohorts, respectively. One- and 3-year adverse kidney events occurred in 5.5% and 13.2% in the development cohort, respectively. The original SPARK score demonstrated an acceptable discriminative power for 1-year and 3-year adverse outcome risks with C indices mostly >0.7. However, the power was relatively poor when restricted to high-risk patients or those who actually developed PO-AKI. When we re-calculated the regression coefficients from a Cox model, the discriminative performances were better, especially for those with high-risk characteristics (e.g. 1-year outcome, C-index 0.72 in developmental and 0.73‒0.77 in validation datasets). Furthermore, when the model integrated the PO-AKI stage and history of malignancy with the SPARK variables, the performance was significantly enhanced (1-year, C-index 0.86 in development and 0.86‒0.88 in validation results). With the above findings, we constructed an online postoperative risk prediction system (https://snuhnephrology.github.io/postop/). Conclusions: The addition of two clinical factors and recalibration of SPARK variables significantly improved mid-to-long-term postoperative risk prediction for mortality or dialysis after non-cardiac surgery. Our calculator helps clinicians easily predict a mid-to-long-term risk and PO-AKI occurrence by entering a few variables.
No takes yet. Share an insight, caveat, or question.
Kwon et al. (2025) conducted a cohort in Postoperative acute kidney injury risk after non-cardiac surgery (n=138,812). Extended SPARK model (integrating PO-AKI stage and history of malignancy) vs. Original SPARK model was evaluated on End-stage kidney disease progression or death within 1 or 3 years after surgery. Integrating PO-AKI stage and history of malignancy with SPARK variables enhanced 1-year adverse kidney outcome prediction.
Synapse has enriched 10 related papers. Consider them for comparative context: